5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
NEUTRAL | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 7.58▲ | 7.58▲ | 7.58▲ | 7.51▼ | 7.82▼ |
MA10 | 7.65▲ | 7.65▲ | 7.77▼ | 7.50▼ | 8.28▼ |
MA20 | 7.70▲ | 7.70▲ | 7.84▼ | 7.80▼ | 8.41▼ |
MA50 | 8.09▼ | 8.12▼ | 8.29▼ | 8.37▼ | 8.24▼ |
MA100 | 8.39▼ | 8.74▼ | 9.18▼ | 8.12▼ | 10.42▼ |
MA200 | 8.79▼ | 8.65▼ | 8.20▼ | 7.99▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.006▲ | 0.006▲ | -0.009▼ | -0.003▼ | -0.172▼ |
RSI | 49.359▼ | 48.857▼ | 47.380▼ | 42.342▼ | 45.144▼ |
STOCH | 28.611 | 28.611 | 26.240 | 27.400 | 17.104▼ |
WILL %R | -61.278 | -61.278 | -61.278 | -87.745▼ | -69.232 |
CCI | 6.980 | 11.454 | 5.152 | -103.279▼ | -89.835 |
Sunday, April 20, 2025 05:00 PM
2.9% of MiNK Therapeutics shares are held by institutional investors. Comparatively, 61.7% of Atyr PHARMA shares are held by institutional investors. 20.6% of MiNK Therapeutics shares are held by ...
|
Saturday, March 29, 2025 05:00 PM
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT ...
|
Saturday, March 29, 2025 05:00 PM
MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 7.40 | 7.40 | 7.40 | 7.40 | 879 |
30/04/25 | 7.80 | 7.80 | 7.452 | 7.452 | 1,649 |
28/04/25 | 7.77 | 8.01 | 7.50 | 7.50 | 1,992 |
25/04/25 | 7.2692 | 7.70 | 7.2692 | 7.70 | 1,177 |
24/04/25 | 7.50 | 7.50 | 7.50 | 7.50 | 1,280 |
23/04/25 | 7.61 | 7.61 | 7.61 | 7.61 | 1,218 |
22/04/25 | 7.45 | 7.675 | 7.41 | 7.535 | 5,542 |
21/04/25 | 7.45 | 7.45 | 7.25 | 7.26 | 2,503 |
17/04/25 | 7.655 | 8.0099 | 7.25 | 7.25 | 2,273 |
16/04/25 | 7.2338 | 7.83 | 7.2338 | 7.83 | 2,805 |
|
|
||||
|
|
||||
|
|